Tofacitinib for recalcitrant cutaneous dermatomyositis

被引：4
|
作者：
Alsarheed, A.
Patel, M.
Vleugels, R.
机构：
[1] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.510
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
503
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] A striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate
    Sozeri, Betul
    Demir, Ferhat
    RHEUMATOLOGY, 2020, 59 (12) : E140 - E141
  • [2] Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment
    Kurtzman, Drew J. B.
    Wright, Natalie A.
    Lin, Janice
    Femia, Alisa N.
    Merola, Joseph F.
    Patel, Mital
    Vleugels, Ruth Ann
    JAMA DERMATOLOGY, 2016, 152 (08) : 944 - 945
  • [3] Apremilast in Recalcitrant Cutaneous Dermatomyositis A Nonrandomized Controlled Trial
    Bitar, Carole
    Ninh, Thien
    Brag, Katherine
    Foutouhi, Soraya
    Radosta, Stella
    Meyers, Jade
    Baddoo, Melody
    Liu, Delong
    Stumpf, Brittany
    Harms, Paul W.
    Saba, Nakhle S.
    Boh, Erin
    JAMA DERMATOLOGY, 2022, 158 (12) : 1357 - 1366
  • [4] Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study
    Shaw, Katharina S.
    Hashemi, Kimberly B.
    Castillo, Rochelle L.
    Rainone, Elizabeth
    Ho, Allen W.
    Kahn, Philip J.
    Oza, Vikash S.
    Femia, Alisa
    Vleugels, Ruth Ann
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1217 - 1219
  • [5] Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment
    Shaw, Katharina S.
    Reusch, Diana B.
    Castillo, Rochelle L.
    Hashemi, Kimberly B.
    Sundel, Robert
    Dedeoglu, Fatma
    Vleugels, Ruth Ann
    JAMA DERMATOLOGY, 2024, 160 (02) : 237 - 238
  • [6] Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib
    Moghadam-Kia, Siamak
    Charlton, Devon
    Aggarwal, Rohit
    Oddis, Chester V.
    RHEUMATOLOGY, 2019, 58 (06) : 1011 - 1015
  • [7] TOFACITINIB IN REFRACTORY JUVENILE DERMATOMYOSITIS
    Lee, Kelley S.
    Patel, Aarat M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 523 - 523
  • [8] TREATMENT OF REFRACTORY DERMATOMYOSITIS WITH TOFACITINIB
    Riggle, K.
    Patel, A.
    Aggarwal, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1592 - 1592
  • [9] Recalcitrant Dermatomyositis Treated With Anifrolumab
    Chaudhary, Shivang
    Baumer, Meghan
    Upton, Laura
    Ong, Samantha
    Smith, Kristin
    West, Daniel
    Kilian, Adam
    ACR OPEN RHEUMATOLOGY, 2025, 7 (01)
  • [10] Treatment of recalcitrant dermatomyositis with efalizumab
    Huber, Andrea
    Gaffal, Evelyn
    Bieber, Thomas
    Tueting, Thomas
    Wenzel, Joerg
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (03) : 254 - 255
12345